Cytokinetics gives 5 new hires options, RSUs under Nasdaq rule

A trader works, as a screen broadcasts a press conference by U.S. Federal Reserve Chair Jerome Powell following the Fed rate announcement, on the floor of the NYSE in New York

Is It Time To Reassess Ascendis Pharma (ASND) After Its 38% One-Year Surge?

Why one Wall Street veteran says risks are piling up that could send the S&P 500 tumbling 35% in the next year

You’ve always wanted to trade the S&P 500 24/7. Here’s a way you can.

Advantage Solutions shareholders approve reverse stock split as company fights Nasdaq delisting